MedTrace Logo

Long-Term Follow-Up Study of Psoriasis Patients

NCT00131066 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2008-09-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the long-term safety and profile of psoriasis patients who have completed participation in a previous study and who received treatment with MEDI-507.

Conditions

Interventions

OTHER

Follow up from previous treatment with MEDI-507

There will be no investigational drugs administered under this protocol.

Sponsors & Collaborators

  • MedImmune LLC

    lead INDUSTRY

Principal Investigators

  • Barbara White, M.D. · MedImmune LLC

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Primary Completion
2003-10-31
Completion
2007-12-31

Countries

  • United States
  • Belgium
  • Canada
  • France
  • Germany
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00131066 on ClinicalTrials.gov